KMT2A and breast carcinoma: PET scanning has been used to visualize the accumulation of myeloid suppressor cells in pre-metastatic lung tissue in a breast cancer model56 and MR-spectroscopy can detect changes in liver metabolism in metastases-free animals carrying MLL-tumors57.